NCT03825575 Sacral Neuromodulation as Treatment for Fecal Incontinence
| NCT ID | NCT03825575 |
| Status | Recruiting |
| Phase | — |
| Sponsor | McMaster University |
| Condition | Fecal Incontinence |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2019-09-08 |
| Primary Completion | 2025-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2019-09-08 with a primary completion date of 2025-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study is to investigate if low level laser therapy will do more good than harm for patients with severe refractory fecal incontinence. It is a proof of concept study without a placebo arm.
Eligibility Criteria
Inclusion Criteria: Patients with fecal incontinence Exclusion Criteria: * Pregnant patients * Known malignancies in the area of treatment * Active bleeding in area of treatment * Active deep vein thrombosis * When tatoos are present at area of treatment * Patients that are light sensitive * Patients who take steroids.
Contact & Investigator
Jihong Chen, MD PhD
PRINCIPAL INVESTIGATOR
McMaster University
Frequently Asked Questions
Who can join the NCT03825575 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 80 Years, studying Fecal Incontinence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03825575 currently recruiting?
Yes, NCT03825575 is actively recruiting participants. Contact the research team at chen338@mcmaster.ca for enrollment information.
Where is the NCT03825575 trial being conducted?
This trial is being conducted at Hamilton, Canada.
Who is sponsoring the NCT03825575 clinical trial?
NCT03825575 is sponsored by McMaster University. The principal investigator is Jihong Chen, MD PhD at McMaster University. The trial plans to enroll 20 participants.